These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6408436)

  • 1. [Blood sugar profile of various mixtures of regular BHI and basal BHI (NPH) in type I and type II diabetic patients].
    Renner R; Vocke K; Hepp KD
    MMW Munch Med Wochenschr; 1983 May; Suppl 1():S57-62. PubMed ID: 6408436
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of fixed-combination preparations of regular BHI and basal BHI (NPH) in type I diabetics].
    Landgraf R; Landgraf-Leurs MM
    MMW Munch Med Wochenschr; 1983 May; Suppl 1():S63-8. PubMed ID: 6408437
    [No Abstract]   [Full Text] [Related]  

  • 3. [Biosynthetic human insulin. Comparison of the activity profile of human NPH-insulin and swine NPH-insulin in type I diabetics].
    Etti H; Haupt E
    MMW Munch Med Wochenschr; 1983 May; Suppl 1():S53-6. PubMed ID: 6408435
    [No Abstract]   [Full Text] [Related]  

  • 4. Preprandial combination of lispro and NPH insulin improves overall blood glucose control in type 1 diabetic patients: a multicenter randomized crossover trial.
    Annuzzi G; Del Prato S; Arcari R; Bellomo Damato A; Benzi L; Bruttomesso D; Calderini MC; Coscelli C; Fedele D; Galluzzo A; Giordano M; Giorgino R; Lapolla A; Orsini P; Pagano G; Santoro D; Riccardi G
    Nutr Metab Cardiovasc Dis; 2001 Jun; 11(3):168-75. PubMed ID: 11590992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proportional dose-response relationship and lower within-patient variability of insulin detemir and NPH insulin in subjects with type 1 diabetes mellitus.
    Wutte A; Plank J; Bodenlenz M; Magnes C; Regittnig W; Sinner F; Rønn B; Zdravkovic M; Pieber TR
    Exp Clin Endocrinol Diabetes; 2007 Jul; 115(7):461-7. PubMed ID: 17647145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin glargine (Lantus).
    Owens DR; Griffiths S
    Int J Clin Pract; 2002; 56(6):460-6. PubMed ID: 12166545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Premeal insulin lispro plus bedtime NPH or twice-daily NPH in patients with type 2 diabetes: acute postprandial and chronic effects on glycemic control and cardiovascular risk factors.
    Ceriello A; Del Prato S; Bue-Valleskey J; Beattie S; Gates J; de la Peña A; Malone J
    J Diabetes Complications; 2007; 21(1):20-7. PubMed ID: 17189870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lower within-subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes.
    Haak T; Tiengo A; Draeger E; Suntum M; Waldhäusl W
    Diabetes Obes Metab; 2005 Jan; 7(1):56-64. PubMed ID: 15642076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin glargine maintains equivalent glycemic control and better lipometabolic control than NPH insulin in type 1 diabetes patients who missed a meal.
    Rosak C; Jung R; Hofmann U
    Horm Metab Res; 2008 Aug; 40(8):544-8. PubMed ID: 18493882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type-1 diabetes mellitus with insufficient serum immunoreactive insulin elevation after subcutaneous NPH-insulin injection.
    Davidson MB
    Diabetes Res Clin Pract; 2004 Jun; 64(3):229. PubMed ID: 15126013
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of the absorption and biological activity of NPH human insulin (recombinant DNA) and NPH porcine insulin injected subcutaneously in type II diabetic patients.
    Bannai C; Kawai K; Murayama Y; Yamashita K
    Horm Metab Res; 1986 Nov; 18(11):784-5. PubMed ID: 3539738
    [No Abstract]   [Full Text] [Related]  

  • 12. Glucose evaluation trial for remission (GETREM) in type 1 diabetes: a European multicentre study.
    Pozzilli P; Manfrini S; Buzzetti R; Lampeter E; Leeuw ID; Iafusco D; Prisco M; Ionescu-Tirgoviste C; Kolouskovà S; Linn T; Ludvigsson J; Madàcsy L; Mrozikiewicz AS; Mrozikiewicz PM; Podar T; Vavrinec J; Vialettes B; Visalli N; Yilmaz T; Browne PD;
    Diabetes Res Clin Pract; 2005 Jun; 68(3):258-64. PubMed ID: 15936469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of conversion from bedtime NPH insulin to morning insulin glargine in type 2 diabetic patients on basal-prandial insulin therapy.
    Yokoyama H; Tada J; Kamikawa F; Kanno S; Yokota Y; Kuramitsu M
    Diabetes Res Clin Pract; 2006 Jul; 73(1):35-40. PubMed ID: 16513202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lasting improvement in the adjustment of insulin-dependent type I and type II diabetics with blood sugar and urinary sugar control by the patient].
    Knick B; Groth U; Koberstein R; Panitz N
    Med Welt; 1983 Jan; 34(1):15-8. PubMed ID: 6338339
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of glycaemic control in patients with Type 2 diabetes on basal insulin and fixed combination oral antidiabetic treatment: results of a pilot study.
    De Mattia G; Laurenti O; Moretti A
    Acta Diabetol; 2009 Mar; 46(1):67-73. PubMed ID: 19030772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Monitoring of blood sugar levels during insulin treatment of diabetes mellitus].
    Chen JW
    Zhonghua Yi Xue Za Zhi; 1984 Mar; 64(3):184-6. PubMed ID: 6432274
    [No Abstract]   [Full Text] [Related]  

  • 17. Insulin analogues and their potential in the management of diabetes mellitus.
    Bolli GB; Di Marchi RD; Park GD; Pramming S; Koivisto VA
    Diabetologia; 1999 Oct; 42(10):1151-67. PubMed ID: 10525654
    [No Abstract]   [Full Text] [Related]  

  • 18. Normal alanine-glucose relationships and their changes in diabetic patients before and after insulin treatment.
    Hall SE; Braaten JT; McKendry JB; Bolton T; Foster D; Berman M
    Diabetes; 1979 Aug; 28(8):737-45. PubMed ID: 446931
    [No Abstract]   [Full Text] [Related]  

  • 19. Parental preference of prandial insulin aspart compared with preprandial human insulin in a basal-bolus scheme with NPH insulin in a 12-wk crossover study of preschool children with type 1 diabetes.
    Danne T; Råstam J; Odendahl R; Näke A; Schimmel U; Szczepanski R; Moeller J; Deiss D
    Pediatr Diabetes; 2007 Oct; 8(5):278-85. PubMed ID: 17850471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Insulin combinations: improving the treatment of juvenile diabetes].
    Gúrpide Arraya N; Durá Travé T; Moya Benavent M
    Rev Enferm; 1997; 20(227-8):17-20. PubMed ID: 9282075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.